{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:11:55Z","timestamp":1791198715642,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","award":["KMOP-1.1.2-07\/1-2008-0003"],"award-info":[{"award-number":["KMOP-1.1.2-07\/1-2008-0003"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","award":["NK83533"],"award-info":[{"award-number":["NK83533"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.bbrc.2012.03.090","type":"journal-article","created":{"date-parts":[[2012,3,24]],"date-time":"2012-03-24T13:01:07Z","timestamp":1332594067000},"page":"869-874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["PI3-kinase and mTOR inhibitors differently modulate the function of the ABCG2 multidrug transporter"],"prefix":"10.1016","volume":"420","author":[{"given":"Csilla","family":"Heged\u00fcs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"Truta-Feles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9za","family":"Antalffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Br\u00f3zik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildik\u00f3","family":"Kasza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"N\u00e9met","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s I.","family":"Orb\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csilla","family":"\u00d6zvegy-Laczka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"V\u00e1radi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Sarkadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2012.03.090_b0005","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1152\/physrev.00037.2005","article-title":"Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system","volume":"86","author":"Sarkadi","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2012.03.090_b0010","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.bcp.2012.01.002","article-title":"Role of breast cancer resistance protein (BCRP\/ABCG2) in cancer drug resistance","volume":"83","author":"Natarajan","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2012.03.090_b0015","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0968-0004(01)01958-2","article-title":"Ten years of protein kinase B signalling: a hard Akt to follow","volume":"26","author":"Brazil","year":"2001","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbrc.2012.03.090_b0020","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrd2062","article-title":"Current development of mTOR inhibitors as anticancer agents","volume":"5","author":"Faivre","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2012.03.090_b0025","doi-asserted-by":"crossref","first-page":"39068","DOI":"10.1074\/jbc.M306362200","article-title":"Akt signaling regulates side population cell phenotype via Bcrp1 translocation","volume":"278","author":"Mogi","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2012.03.090_b0030","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1124\/dmd.104.003228","article-title":"Regulation of the cell surface expression of human BCRP\/ABCG2 by the phosphorylation state of Akt in polarized cells","volume":"33","author":"Takada","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2012.03.090_b0035","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.stem.2009.01.007","article-title":"PTEN\/PI3K\/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells","volume":"4","author":"Bleau","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbrc.2012.03.090_b0040","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/labinvest.3700127","article-title":"Subcellular localization of the ABCG2 transporter in normal and malignant human gallbladder epithelium","volume":"84","author":"Aust","year":"2004","journal-title":"Lab Invest."},{"key":"10.1016\/j.bbrc.2012.03.090_b0045","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/carcin\/bgn223","article-title":"Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling","volume":"29","author":"Hu","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrc.2012.03.090_b0050","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.bcp.2012.01.033","article-title":"Inhibition of the PI3K-Akt signaling pathway disrupts ABCG2-rich extracellular vesicles and overcomes multidrug resistance in breast cancer cells","volume":"83","author":"Goler-Baron","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2012.03.090_b0055","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1182\/blood-2005-10-4020","article-title":"Complex interaction of BCRP\/ABCG2 and imatinib in BCR-ABL-expressing cells: BCRP-mediated resistance to imatinib is attenuated by imatinib-induced reduction of BCRP expression","volume":"108","author":"Nakanishi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2012.03.090_b0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00280-006-0357-8","article-title":"Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins","volume":"60","author":"Pawarode","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbrc.2012.03.090_b0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/bj3510095","article-title":"Specificity and mechanism of action of some commonly used protein kinase inhibitors","volume":"351","author":"Davies","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2012.03.090_b0070","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00280-005-0173-6","article-title":"Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan","volume":"58","author":"Gupta","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbrc.2012.03.090_b0075","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/sj.onc.1209201","article-title":"The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1","volume":"25","author":"Abdul-Ghani","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2012.03.090_b0080","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1124\/mol.65.6.1485","article-title":"High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter","volume":"65","author":"Ozvegy-Laczka","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2012.03.090_b0085","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1158\/0008-5472.CAN-04-3303","article-title":"Multidrug transporter ABCG2 prevents tumor cell death induced by the epidermal growth factor receptor inhibitor Iressa ZD1839, Gefitinib","volume":"65","author":"Elkind","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2012.03.090_b0090","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.bbrc.2007.12.172","article-title":"Combined localization and real-time functional studies using a GFP-tagged ABCG2 multidrug transporter","volume":"367","author":"Orban","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2012.03.090_b0095","doi-asserted-by":"crossref","first-page":"47980","DOI":"10.1074\/jbc.M207857200","article-title":"Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter Modulation of substrate specificity by a point mutation","volume":"277","author":"Ozvegy","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2012.03.090_b0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/bbrc.2001.5130","article-title":"Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells","volume":"285","author":"Ozvegy","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2012.03.090_b0105","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1016\/j.bbamem.2007.06.026","article-title":"Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter","volume":"1768","author":"Telbisz","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2012.03.090_b0110","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0898-6568(01)00201-7","article-title":"Activation of Raf\/ERK1\/2 MAP kinase pathway is involved in GM-CSF-induced proliferation and survival but not in erythropoietin-induced differentiation of TF-1 cells","volume":"13","author":"Kolonics","year":"2001","journal-title":"Cell Signal."},{"key":"10.1016\/j.bbrc.2012.03.090_b0115","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm0901-1028","article-title":"The ABC transporter Bcrp1\/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype","volume":"7","author":"Zhou","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2012.03.090_b0120","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1074\/jbc.M411338200","article-title":"Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface","volume":"280","author":"Ozvegy-Laczka","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2012.03.090_b0125","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1124\/jpet.106.119289","article-title":"Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2","volume":"321","author":"Pal","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbrc.2012.03.090_b0130","first-page":"101","article-title":"Antibody binding shift assay for rapid screening of drug interactions with the human ABCG2 multidrug transporter European journal of pharmaceutical sciences: official journal of the Eur","volume":"45","author":"Telbisz","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbrc.2012.03.090_b0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.addr.2008.09.007","article-title":"Ins and outs of the ABCG2 multidrug transporter: an update on in vitro functional assays","volume":"61","author":"Hegedus","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbrc.2012.03.090_b0140","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.drudis.2007.12.010","article-title":"The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox)","volume":"13","author":"Szakacs","year":"2008","journal-title":"Drug Discov. Today"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X12005505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X12005505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T10:58:34Z","timestamp":1757761114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X12005505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0006291X12005505"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2012.03.090","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PI3-kinase and mTOR inhibitors differently modulate the function of the ABCG2 multidrug transporter","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2012.03.090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}